Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the safety, pharmacodynamics (PD), and
pharmacokinetics (PK) of multiple subcutaneous injections of peginesatide in participants
with chronic kidney disease (CKD) not on dialysis who had not received erythropoiesis
stimulating agent (ESA) treatment.